Correlation Between Equillium and Aclaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both Equillium and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Aclaris Therapeutics, you can compare the effects of market volatilities on Equillium and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Aclaris Therapeutics.
Diversification Opportunities for Equillium and Aclaris Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Equillium and Aclaris is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Equillium i.e., Equillium and Aclaris Therapeutics go up and down completely randomly.
Pair Corralation between Equillium and Aclaris Therapeutics
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Aclaris Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Equillium is 1.69 times less risky than Aclaris Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Aclaris Therapeutics is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 180.00 in Aclaris Therapeutics on August 31, 2024 and sell it today you would earn a total of 202.00 from holding Aclaris Therapeutics or generate 112.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Aclaris Therapeutics
Performance |
| Timeline |
| Equillium |
| Aclaris Therapeutics |
Equillium and Aclaris Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Aclaris Therapeutics
The main advantage of trading using opposite Equillium and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.| Equillium vs. Cue Biopharma | Equillium vs. Tff Pharmaceuticals | Equillium vs. Eliem Therapeutics | Equillium vs. Inhibrx |
| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |